POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Texas House Bill 1987 modifies abortion reporting requirements, regulates abortion-inducing drugs, and repeals specific abortion prohibition laws

Original title: Relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.

Last action · March 14, 2025: Referred to Public HealthSponsor: Rhetta Bowers

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

Texas HB 1987 requires physicians and health care facilities to report specific s, mandates that abortion-inducing drugs follow FDA labels or specific clinical guidelines, and repeals Chapter 170A of the Health and Safety Code and other related laws effective September 1, 2025.

Why it matters

The measure alters compliance and reporting obligations for medical practitioners providing abortion care, alters the legal framework governing medication abortion protocols, and changes the statutory prohibitions on abortion in the state.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Physicians

Physicians must follow updated FDA or clinical guideline protocols when providing abortion-inducing drugs, document gestational age and intrauterine location, schedule follow-up visits, and report specific abortion complications.

Directly affected

Health care facilities

Hospitals, abortion facilities, and emergency medical care facilities are subject to mandatory reporting requirements when diagnosing or treating abortion complications.

Directly affected

Pregnant women seeking abortions

Patients receiving abortion-inducing drugs must undergo a pre-procedure examination, have their data documented in medical records, and attend a mandatory follow-up visit within 14 days.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

What medical complications must be reported under this bill?
Reportable s include shock, uterine perforation, cervical laceration, hemorrhage, aspiration or allergic response, infection, sepsis, patient death, incomplete abortion, damage to the uterus, or an infant born alive after the abortion.
When does the follow-up visit need to occur after taking an abortion-inducing drug?
The follow-up visit must be scheduled to occur not later than the 14th day after the administration or use of the abortion-inducing drug.
What laws are repealed by the measure?
The bill repeals Chapter 170A of the Health and Safety Code, Section 171.061(2-a), Section 171.063(b-1), Sections 171.0631 and 171.0632, Sections 171.065 and 171.066, and Chapter 6-1/2, Title 71, Revised Statutes.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died at adjournment · in House committee.

Procedural history

3 actions
  1. Mar 14, 2025HouseCommittee
    Referred to Public Health
  2. Mar 14, 2025HouseIntroduced
    Read first time
  3. Jan 22, 2025HouseIntroduced
    Filed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift95% confidence

Modification of Abortion Regulation and Reporting

The bill updates definitions for abortion complications and reporting obligations while repealing Chapter 170A and other designated abortion prohibition laws.

Connected Entities

American College of Obstetricians and Gynecologists, Health and Safety Code, United States Food and Drug Administration
OrganizationAmerican College of Obstetricians and Gynecologists“defines clinical management guidelines for abortion-inducing drug dosages”Map →
otherHealth and Safety Code“statutory code amended and partially repealed by the bill”Map →
OrganizationUnited States Food and Drug Administration“approves informational documents and protocols for abortion-inducing drugs”Map →

Sources

Open source document

capitol.texas.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 80)
  • Controversy95
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz75
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record